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Immunoglobulin M  antibody bound to  erythrocyte membranes fixes  com- 
plement more effectively on a  molar basis  than immunoglobulin G  antibody 
(1,  2).  However,  the addition of IgM  ~ antiglobulin (rheumatoid factor [RF]) 
to IgG complexed with cell-surface antigens actually reduces the  amount of 
complement fixed below the amount observed with IgG alone (3, 4,  5).  This 
finding initially led to the belief that the IgM in question, human rheumatoid 
factor, lacked the capacity to fix complement, an observation subsequently dis- 
proven when it was shown that IgM-RF like most other IgM molecules did 
indeed possess  this ability (6,  7,  8).  Therefore,  the decreased effect observed 
when IgM is reacted with IgG complexed with cell membranes must be  ex- 
plained on other grounds. 
This report presents evidence that complement fixation in this two component 
antibody system is  critically dependent upon  the concentration of IgG. The 
addition of purified IgM-RF to high concentrations of IgG antibody on erythro- 
cytes reduces the amount of complement fixation compared to that observed 
with IgG alone. Addition of IgM-RF to low concentrations of IgG antibody 
produces  enhancement of  complement fixation. 
Materials and Methods 
Rheumatoid Factor Preparation.--High-titered  sera from patients with rheumatoid arthritis 
were absorbed by sheep cells and euglobulin fractions obtained by dilution with 14 volumes of 
* Supported  in part  by research grant  AM  11513, U.  S.  Public Health  Service, and  by 
grants from The Medical Research Council, United Kingdom. 
1 Abbreviations  used  in  this  paper:  BDB-HGG,  bis-diazotized  benzidine-human  gamma 
globulin  (Cohn Fraction II); Clq, the llS unit of the first component of complement; Rlq, 
reagent  deficient  in  Clq  but  containing  the  remaining  components  of  complement;  RF, 
rheumatoid factor; SCAT, sheep red cell agglutination test for rheumatoid factor. 
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distilled water, the pH being brought to 6.0 by careful addition of dilute HC1. The precipitate 
was suspended in a volume of phosphate-buffered saline, pH  7, equal to that of the original 
serum, centrifuged at 4°C  to float off lipid material, and kept in small portions at  -20°C. 
Purified RF was obtained either from such euglobulin preparations or from whole serum by 
adsorption onto insoluble human gamma globulin cross-linked by bisdiazotized benzidine (9), 
and elution by 0.3 M acetate buffer, pH 4.0. In later experiments, the acid eluates were further 
purified by  sucrose density ultracentrifugation employing gradients  of  10-40%  sucrose  in 
acetate buffer, the 19S fraction being dialyzed against phosphate buffer pH 7.0. These prepa- 
rations had a protein content of 1.0-1.5 mg/ml and gave a single IgM line on immunoelectro- 
phoresis and a single 19S peak on analytical ultracentrifugation. After analysis, bovine serum 
albumin was added to a concentration of 10 mg/ml and stored at -20°C. Such purified prepa- 
rations maintained their potency for up to 12 months. 
The agglutinating ability of RF was assayed by a microtiter technique against sheep cells 
sensitized with one quarter the amount of rabbit anti-sheep erythrocyte serum needed to cause 
agglutination. Sera or fractions being tested were first absorbed with sheep cells. The agglu- 
tinating titer was expressed as the reciprocal of the highest dilution causing maximal agglu- 
tination. 
Hemolytic Antibodies.--Rabbit antiserum to sheep red blood cells was either obtained com- 
mercially (Markham Laboratories, Chicago, Ill. and Burroughs Wellcome, London, England) 
or prepared by immunization with sheep red blood cell stromata  (10).  Immunoglobulin G 
antibody was separated from IgM: IgG by elution of the breakthrough peak from diethyl- 
aminoethyl-cellulose in 0.01  ~  phosphate buffer, pH  8.0,  and IgM by one or two passages 
through a  column of Sephadex G200.  Completeness of separation was assessed by immuno- 
electrophoresis using commercial antisera against rabbit serum and an antibody preparation 
against rabbit IgM kindly supplied by Doctor Parker Small. Bovine serum albumin, 10 rag/ 
ml, was added to samples of the purified antibodies which were stored at -20°C. 
Determination of Complement Levels.--Whole serum was assayed for its complement titer 
(CH~0 units/ml) by the method of Kabat and Mayer (10) except for a reduction to 40% of the 
volume of reagents employed. Results, however, are expressed in the text and figures in terms 
of the standard 7.5 ml volume of reagents. Sheep erythrocytes were sensitized with an amount 
of either IgM or IgG hemolysin just sufficient to give optimal lysis in the presence of 1-2 
CHs0 units of human serum previously absorbed with sheep cells to remove natural hemolytic 
antibody. Such cells were designated as sensitized with 1.0 unit of antibody. Traces of self- 
agglutination were observed at  this concentration with IgG hemolysin but not with IgM 
hemolysin. These cells were added to dilutions of the sera to be tested in 13 X  100 mm tubes, 
incubated for 60 rain at 37°C  with periodic swirling of the contents, centrifuged, and the 
supernatant fluid read for hemolysis at 541  m# in  a  spectrophotometer.  Determination of 
CHs0 was made on probit graph paper from lines determined by three or more points (11). 
In later experiments, before using red cells,  we washed them twice with ethylenediamine- 
tetraacetate, pH 7.0, 0.01 M in saline to remove trace amounts of the first component of com- 
plement (1). Results with such cells were similar to those obtained without this step. 
Complement Components.--Clq (the llS unit of the first component of complement) was 
obtained from fresh human sera free of RF by the method of Morse and Christian (12)  except 
that insoluble bis-diazotized benzidine--human gamma globulin (BDB-HGG) was used as an 
adsorbant rather than heat-aggregated globulin. Elufion was accomplished by 0.3 ~r acetate 
buffer, pI-I 4.5,  and  the  acid  eluate further purified by column chromatography on  G200 
Sephadex; after this it was concentrated and dialyzed against phosphate buffer, pH 7.0. Such 
preparations were contaminated by trace amounts of IgG and occasionally by other proteins, 
as determined by immunodiffusion. On sedimentation-velocity ultracentrifugation, a  major 
11S peak was obtained. Protein concentrations ranged between 1.0 and 2.0 mg/ml. Bovine 
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A reagent deficient in Clq (Rlq) was prepared from normal human serum (13) by use of 
insoluble BDB-HGG as an absorbant. Such preparations were unable to lyse optimally sensi- 
tized sheep blood cells but activity could be restored by addition of purified Clq. 
Complement Inhibition and Enhancement Assays.--RF preparations or control materials to 
be tested for their effect upon hemolysis were added to dilutions of a standard normal human 
serum from which natural hemolytic antibody had been completely removed by two absorp- 
tions with sheep red blood cells at 0°C for 5-10 min each. A volume of 0.1 ml of purified RF 
or 0.4 ml of euglobulin preparation to be tested was used in the 40% assay system which would 
be equivalent to 0.25 ml and 1.0 ml respectively in the full-voinme method (10). The mixture 
was then assayed for complement activity by the addition of cells coated with 1.0 unit of 
IgG antibody or of cells coated with lesser amounts (0.1-0.7 units) of IgG antibody. Parallel 
experiments were set up without the addition of RF preparations. The order of addition of 
reagents for these tests was as follows.  The buffer, test material, and serum dilution used as a 
source of complement were added to  13 x  100 mm tubes kept at 0°C.  Sensitized cells were 
then added and the mixture incubated at 37°C  for I hr with repeated mixing of the contents 
at 10-15 min intervals. In other experiments, the order of addition was changed as indicated 
in the text. Removal of unbound antibody or RF by washing cell mixtures prior to the addi- 
tion of complement serum did not alter the degree of lysis from that obtained without this 
step. 
Results of these assays were calculated in two ways. In one, they were expressed as the 
change in the number of CHs0 units of complement detected after the addition of the test 
material. Inhibition of complement activity was reflected by the lesser number of CH~0 units 
observed, and enhancement by the greater number. By definition, CHs0 units can only be 
employed when using cells coated with optimal (1.0 unit) amounts of IgG hemolytic antibody 
(10).  Therefore, data from experiments in which suboptimal amounts (less than 1.0 unit) of 
IgG antibody were used to coat cells are reported as the change in the percentage of lysis 
achieved in the presence of a fixed number of CHs0 units of complement. In this second expres- 
sion, inhibition of complement activity was indicated by a lesser percentage of lysis, and en- 
hancement by a greater percentage. With reduction in the amount of IgG antibody employed, 
larger amounts of complement were used to achieve hemolysis within the measurable range of 
20-80% since an inverse hemolytic relationship exists for the amounts of sensitizing antibody 
and complement  (Fig.  4). 
Kinetic Experiments of Complement Inhibition.--Reaction mixtures were prepared in 50 ml 
stoppered Erlenmeyer flasks that were constantly agitated in an oscillating 37°C water bath. 
Materials were added in the order described in the text to a total volume of 15 ml. Zero time 
was recorded at the time of addition of the Rlq reagent. At timed intervals thereafter, one ml 
samples were withdrawn into iced tubes containing 2 ml of 0.005 M ethylene diamine tetra- 
acetate in phosphate saline buffer, pH 7.0,  and immediately centrifuged. Supernatant fluids 
were tested for degree of hemolysis as already noted. 
RESULTS 
Effect of Rheumatoid Factor on Immune Lysis of Erythrocytes Coated with Optimal 
(1,0 Unit) Concentrations of IgG Hemolysin 
Euglobulin  Preparations from Rheumatoid Patients.--Euglobulin preparations 
from  six  adults  with  rheumatoid  arthritis  and  four  normal  individuals  were 
tested  for  their  ability  to  influence  hemolysis  using  standard  normal  human 
sera  absorbed  with  sheep  erythrocytes  as  sources  of  complement  (Table  I). 
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sensitized with  either IgM  or IgG hemolysins,  although  slightly higher values 
were usually obtained with  the IgM  coat. 
To  differentiate  between  complement  fixation  occurring  on  the  membrane 
where  RF  binds  to  IgG  from  a  nonspecific  reaction  of  the  preparation  with 
TABLE  I 
Effect of Euglobulin Serum Fractions  from Patients with Rheumatoid Arthritis and from Normal 
Individuals upon Complement-Mediated Lysis of Sheep Erythrocytes Coated with 
Optimal (1.0 unit) Amounts of Either IgG or IgM Rabbit Hemolysin 
Euglobulin donor 
IgG coat  IgM coat 
(CHs0 units measured)  (CH~0 units measured)  CH~0 change 
due to euglob-  SCAT* 
Standard  Change  ulln  acting  titer  Stand-  Standard  Change  Standard  serum -b  due to  via cell-bound  ard  serum q-  due to 
euglob-  euglobul~n  serum  euglob-  euglob-  IgG coat 
serum  ulin  ulin  ulin 
R.A. Patients 
MOR  33.4  5  -28.4  35.7  28.3  -7.4  -21  1536 
PAR  33.4  5  --28.4  35.7  32.6  --3.1  --25.3  768 
WOR  32.3  13.7  --18.6  32.3  26.3  --6  --12.6  1024 
24  14  --10  29  30  +1  --11 
LIF  21.7  5  --16.7  25.4  21.3  --4.1  --12.6  512 
BAK  21.7  5  --16.7  25.4  29  +3.6  --20.3  64 
DEL  21.7  20  --1.7  25.4  31.9  +6.5  --8.2  16 
Normals 
PEG  21.7  16.1  --5.6  25.4  18.2  --7.2  +1.6  <4 
GLE  24  36  +12  29  35  +6  +6  <4 
33.4  31.9  --1.5  35.7  31.9  --3.8  +2.3 
DAV  24  29  +5  29  35  +6  -- 1  <4 
32.3  38.4  +6.1  32.3  40  +7.7  -1.6 
33.4  33.4  0  35.7  36.5  +0.8  -0.8 
BAN  33.4  37.5  +4.1  35.7  37.5  +1.8  +2.3  <4 
21.7  17.3  --4.4  25.4  20.8  --4.6  --0.2 
Values refer to the number of CHs0 units measured per milliliter of the standard  serum. 
* Sheep red  cell agglutination test for rheumatoid factor;  reciprocal of maximum  posi- 
tive dilution. 
complement, the effect of euglobulin on the lysis of IgM-coated cells was tested. 
Since RF does not react with IgM, any reduction in lysis would be attributable 
to  nonspecific  complement  consumption.  When  the  euglobulin  fraction  was 
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augmentation  of  complement  action were noted.  However,  with the IgG  coat, 
marked inhibition occurred in the presence of rheumatoid euglobulin. Inhibition 
of  complement  activity  specifically  related  to  blockage  of  interaction  at  the 
antibody site on the cell membrane  was computed  by subtracting any comple- 
TABLE  II 
Effect o/Rheumatoid  Factor Purified from Euglobulin Preparations on Complement-Mediated 
Immune Hemolysis. Eugtobulins were Absorbed with Insoluble Human Gamma 
Globulin (BDB-HGG) and the Rheumatoid Factors Eluted with Acid 
CHs0 change 
Change in CH~0  due to prepara-  SCAT] 
tion acting via  Preparation*  IgG Coat*  IgM Coat:~  cell-bound  titer 
IgG coat 
R.A. Patients 
MOR:  eluted RF  --20.4  +2.8  --23.2  32 
absorbed euglobulin  --11.5  --7  --4.5  <4 
LIF:  elutedRF  --19.7  +1.3  --21  32 
absorbed euglobulin  -- 7.8  -- 2.4  -- 5.4  < 4 
"FOB:  elutedRF  --15  +6.1  --21.1  16 
absorbed euglobulin  --4.4  +6.1  -  10.5  4 
PAR:  eluted RF  --8.5  +4.4  --12.9  8 
absorbed euglobulin  -  30  -  32  + 2  < 4 
WOR:  eluted RF  -  1.2  +2.8  -4  4 
absorbed euglobulin  +1.3  +2.8  --1.5  <4 
DEL:  eluted RF  +10  +2.8  +7.2  <4 
absorbed euglobulin  -3.4  0  -3.4  <4 
Normals 
CAM:  eluted RF  +1.3  +1.3  0  <4 
absorbed euglobulin  -- 6.2  -- 5.4  -- 0.8  < 4 
PEG:  eluted RF  +4.4  +2.8  +1.6  <4 
absorbed euglobulin  -- 6.2  -- 4.4  -- 1.8  < 4 
* RF preparations in this particular experiment only were not further purified by sucrose 
density ultracentrifugation. 
:~ Standard human serum alone contained 32 CH~0 units/ml in assays with erythrocytes 
coated with optimal amounts of either IgG or IgM rabbit hemolysin. 
§ Sheep red cell  agglutination test for rheumatoid  factor;  reciprocal  of  maximum  posi- 
tive dilution. 
ment effect found with IgM-coated  cells from that found with IgG-coated cells. 
All  rheumatoid  euglobulins  tested,  but  none from  normal  individuals lacking 
RF,  were inhibitory. 
Purified Rheumatoid Factor.--The essential role of RF in this inhibition on the 678  IGG  CONCENTRATION  AND  COMPLEMENT  FIXATION  BY  IOM-RF 
cell membrane was confirmed by using a  purified preparation rather  than the 
euglobulin fraction. A series of eight euglobulins,  six from patients with rheuma- 
toid arthritis  and two from normal  individuals,  were absorbed onto insoluble 
BDB-HGG. The supernatant fluids from such mixtures as well as the material 
eluted from the BDB-HGG were tested for their effect upon hemolysis using 
cells  optimally coated with IgM and IgG hemolysin  (Table II). The eluates 
which were positive in  the sheep cell  agglutination test inhibited  lysis in  the 
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FIG. 1.  Complete recovery in the supernatant fluid of complement activity not fixed by 
rheumatoid factor--IgG system. Incubation I: Cross-hatched bars indicate number of CH60 
units of complement consumed after 5 min incubation at 37°C by sheep erythrocytes opti- 
mally sensitized by IgG or IgM hemolysin in the presence or absence of rheumatoid factor. 
Incubation II: Open bars indicate number of CH~0 units of complement remaining in the 
supernatant fluids after the above incubation when tested by sheep erythrocytes optimally 
sensitized by IgM hemolysin. 
IgG system but had no such comparable effect upon the IgM system. In con- 
trast,  the absorbed euglobulin preparations were often anti-complementary in 
the IgM system and the difference in effect observed between IgG- and IgM- 
coated  cells  was  markedly  lower  than  that  obtained  with  the  purified  RF 
preparations.  This  was  particularly  evident  with  the  supernatant  resulting 
from absorption of the euglobulin from patient PAR which almost completely 
inhibited lysis of both IgM- and IgG-coated erythrocytes. 
Further evidence that inhibition of complement activity by RF was due to 
blockage of its attachment to the antibody site on the cell membrane and not 
to the result of its destruction or utilization in the liquid phase was shown in the FRANK  R.  SCHMID,  IVAN  M.  ROITT,  AND  MARIA  J.  ROCHA  679 
following experiment. Using a standard normal serum absorbed by sheep cells, 
approximately 40%  of  complement activity was  consumed  after  incubation 
with  either  IgG- or IgM-coated  erythrocytes,  the  remaining  60%  being  de- 
tected in the supernatant when subsequently incubated at 37°C for 60 min with 
IgM-coated cells (Fig. 1). When RF was added, about 40% of complement was 
again consumed by IgM-coated cells but only 16% by IgG-coated cells.  The 
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FIG. 2.  Correlation of SCAT titer of purified rheumatoid factors with specific inhibition of 
complement-mediated lysis of erythrocytes coated with optimal amounts of IgG hemolysin. 
Bar indicates arithmetic mean. The standard serum contained 32 CHs0 units/ml of comple- 
ment. Any anticomplementary effects of the rheumatoid factor preparation as detected by 
inhibition of lysis of IgM-coated cells were deducted to obtain the specific inhibition of com- 
plement attachment to cell-bound antibody. 
remaining complement in each supernate was completely recovered when tested 
with  IgM-coated cells.  The initial  incubation  time had  to be shortened  to  5 
min since no measurable complement could be subsequently demonstrated in 
any of the supernates if this period was extended to 15 min or longer. 
Relationship  between Agglutinating Tiler and Inhibitory Activity of Rheumatoid 
Factor.--A  direct  relationship  was  found  to  exist between  the  agglutinating 
titer  of RF  and  its  effectiveness in  blocking complement-dependent lysis  of 
optimally sensitized sheep cells. A total of 22 RF preparations from 16 different 
patients had been derived from either the euglobulin fraction or whole serum 680  IGG  CONCENTRATION AND  COMPLEMENT  FIXATION  BY  IGM-RF 
by  absorption  with  BDB-HGG  and  elution,  and  were  compared  (Fig.  2). 
Agglutination  titer correlated well with ability to inhibit complement fixation 
(r =  0.91; P  <  0.001). In another experiment, the inhibitory effect of three RF 
preparations was studied  over a  wider range of concentrations  using erythro- 
cytes  coated with  two  different  amounts  of IgG hemolysin.  At  optimal  (1.0 
unit) levels of sensitization, increasing quantities of RF led to greater degrees of 
inhibition;  at levels of sensitization  two-thirds  optimal,  a  similar but slightly 
greater inhibitory pattern was demonstrated.  Complete inhibition of lysis was 
not achieved even with the maximal amounts of RF used (Fig. 3). 
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Fro. 3.  Progressive  inhibition of immune lysis of IgG-coated red cells by increasing concen- 
trations of three purified rheumatoid factors. Individual rheumatoid factors are indicated by 
different symbols. Red cells sensitized with 1.0 unit of antibody for preparations [], O, and 
sensitized with 0.67 unit of antibody for preparation 0. 
t~'ect of Rheumatoid Factor on Immune Lysis of Erythrocytes Coated with 
Suboptimal  (< 1.0 Unit) Concentrations of IgG Hemolysin 
Euglobulin  Preparation from  a  Rheumatoid  Patient.--Erythrocytes  which 
were coated with one-tenth of an optimal amount of IgG hemolysin measured 
just 2.3  CHs0 units out of the 24 actually present in a standard normal serum 
(Table  III). Unexpectedly,  the  addition  of  a  euglobulin  preparation  from a 
rheumatoid  patient  increased  the  amount  of  complement  activity  detected 
while that from a normal individual did not. When erythrocytes were sensitized 
with 0.4 unit IgG antibody,  enhancement by rheumatoid euglobulin no longer 
could be demonstrated. Rather,  at this level of antibody and at optimal or 1.0 
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Purified Rheumatoid  Factor.--Constant  amounts  of seven  RF  preparations 
obtained from the  sera  of four patients  were  evaluated  for  their  effect upon 
complement-dependent hemolysis using erythrocytes that had been sensitized 
with varying amounts of IgG hemolysin. Barely detectable degrees of hemolysis 
with unsensitized cells were noted for several of the RF preparations indicating 
that  a  trace  amount  of  natural  hemolytic  antibody  still  persisted  after  two 
prior absorptions with sheep cells (Table IV). Both at 0.1 and 0.2 units of anti- 
body sensitization,  the addition  of each RF strikingly enhanced the degree of 
TABLE III 
Effect  of Euglobulin  Serum  Fractions from a Patient  with Rheumatoid Arthritis and from a 
Normal  Individual  upon  Complement-Mediated Lysis of Sheep Erythrocytes Coated with 
Optimal  (1.0 unit)  and Suboptimal  (0.4 and 0.1 unit)  Amounts  of IgG and Optimal 
(I.0 unit) Amounts  of IgM Rabbit Hemolysin 
IgG coat  IgM coat  CHso 
(CH6o units measured)  (CHso units measured)  change 
due to 
Standard  Change  Stand-  euglob-  SCAT*  Degree of IgG sensitization  Stand-  serum +  due to  Stand-  ard  Change  ulin act-  titer 
ard  euglob-  euglob-  ard  serum +  due to  euglob-  ing via cell- 
serum  ulin  ulin  serum euglob-  bound 
ulin  ulin  IgG coat 
R.A. Patient (WOR) 
1.0  24  14  --10  29  30  +1  --11  1024 
0.4  8.3  5.3  --3  (768) 
0.1  2,3  5.3  +3  (48) 
0  0  0  0  (<6) 
Normal (DAV) 
1.0  24  29  +5  29  35  +6  -  1  <4 
0.4  8.3  5.3  -3  (<6) 
0.1  2.3  0.7  --1.8  (<6) 
o  0  o  o  (<6) 
Values refer to the number of CHs0 units measured per milliliter of the standard serum. 
* Sheep red cell agglutination  test for rheumatoid  factor; reciprocal of maximum positive 
dilution. Values in parentheses obtained using cells sensitized with IgG antibody at the same 
concentration  used for respective complement assay. 
hemolysis  noted.  This  enhancement  became  more marked  as  the  number  of 
units of complement was increased from a  minimal  quantity of  1.75 up to 8.5 
CHs0 units.  At 0.5  units of antibody sensitization,  slight inhibition  of lysis at 
minimal  amounts,  and  slight  enhancement  at maximum  amounts  of comple- 
ment were noted. At optimal  (1.0 unit) levels of antibody sensitization,  inhibi- 
tion of lysis could easily be demonstrated,  confirming earlier results.  Although 
not indicated in the table, none of the RF preparations influenced the degree of 
lysis observed with control cells coated with optimal amounts of IgM hemolysin 
nor,  in the case of a few preparations,  with lesser amounts of IgM hemolysin 
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Absorption  Studies  of a  Rheumatoid Factor Preparation.--The  essential role 
of RF in these reactions was confirmed by absorption studies of a  potent prepa- 
ration  by BDB-HGG.  Removal of agglutinating activity was associated with 
loss of both the inhibiting and enhancing effects of the preparation (Table V). 
TABLE  IV 
Effect of Purified Rheumatoid Factors upon Complement-Mediated Lysis of Sheep Erythrocytes 
Coated with Varying Amounts of IgG Rabbit Hemolysin 
Rheumatoid factor  SCAT* 
Relative IgG hemolysin  concentration 
0  0.1  0.2  0.5  1.0 
1.75 CHs0 units 
HAL~43  2048  1  12  22  32  35 
WEG--42  2048  1  3  8  24  51 
VAN--41  2048  1  4  8  24  47 
None  --  0  0  0  40  85 
5.8 CHso units 
KIS  2048  0  7  27  55 
WEG  1024  0  I  12  54 
VAN  128  0  1  6  84 
None  --  0  0  0  94 
6.0 CHso units 
HAL  256  4  78  86  82 
None  --  0  24  92  98 
8.5 CHgo units 
HAL--43  2048  3  76  89  100  100 
WEG--42  2048  2  31  74  100  100 
VAN--41  2048  3  29  65  100  100 
None  --  0  8  41  90  100 
Values refer to the percentage lysis observed. 
* Sheep red  cell  agglutination test  for rheumatoid factor;  reciprocal of maximum  pos- 
itive dilution. 
TABLE  V 
Effect of Absorption of a Rheumatoid Factor Preparation by BDB-HGG upon its  Ability  to 
Influence Complement-Mediated Lysis  of Erythrocytes Coated with  Varying Amounts  of 
IgG Hemolysin 
Rheumatoid factor  SCAT* 
(KIS) 
Relative IgG hemolysin  concentration 
0  0.1  0.2  1.0 
Unabsorbed  480  0  3  20  63 
Absorbed  < 15  0  0  0  93 
None  --  0  0  2  100 
Values refer to the percentage of lysis observed in the presence of 5.5 CH50 units of com- 
plement. 
* Sheep  red  cell  agglutination  test for rheumatoid factor;  reciprocal of maximum  pos- 
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In the experiments recorded in Table IV, some of the RF preparations were 
able  to  induce  definite but  insignificant degrees  of  lysis of  unsensitized  cells 
even  though  each preparation had been twice absorbed with sheep cells prior 
to use. This raised the possibility that trace amounts of residual natural hemo- 
lytic antibody in the preparation might potentiate the degree of sensitization 
TABLE VI 
Effect of Five Successive Absorptions "with Sheep Erythrocytes upon the Ability  of a Rheumatoid 
Factor Preparation to Influence Complement-Mediated Lysis  of Erythrocytes Coated with 
Varying Amounts of IgG Hemolysin 
Absorbed supernate 
IgGconcentration  Absorbing  No. of absorptions*  SCATS  cells 
0  0.1  0.2  0.4  1.0 
Unabsorbed  512  0  27  41  47  89  -- 
No RF§  1  2  13  81  100 
1  512  0 
2  512  0 
3  512  1  26  41  43  90  0 
No RF  1  2  11  79  99 
4  256  0 
5  256  1  26  41  41  91  0 
No RF  2  2  13  80  99 
Values refer to the percentage lysis observed in the presence of 3.1 CH~0 units of com- 
plement. 
* 1.6 ml rheumatoid factor preparation absorbed with five successive portions of 5 X  10  8 
sheep red cells. Each sample of absorbing cells tested for lysis using 3.1 CHs0 units of com- 
plement. 
Sheep  red cell agglutination test for rheumatoid factor; reciprocal of  maximum pos- 
itive dilution. 
§ Control without added RF. 
of cells coated with suboptimal concentrations of IgG hemolysin. Therefore, RF 
was absorbed five times with sheep erythrocytes. Each sample of cells used in 
absorption, when subsequently tested, was unable to generate lysis in the pres- 
ence  of  complement  (Table VI). No  significant fall in  SCAT  (sheep  red cell 
agglutination test)  titer was noted in the absorbed RF preparation and, when 
tested after the last absorption it was still able to either inhibit or enhance lysis 
depending on the IgG antibody concentration. 
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toid Factor.--A positive correlation existed between the degree of enhancement 
of immune lysis and the agglutinating titer of the RF. Such a tendency was sug- 
gested in a  previous experiment  in which three RF preparations,  each with  a 
different  titer  (Table  IV  at  5.8  CHs0  units),  caused  increasing  amounts  of 
hemolysis with  increasing  agglutinating  titers.  In a  further  experiment,  three 
other preparations caused progressively greater lysis with each fourfold increase 
of agglutinating titer (Table VII). Two of these three equipotent agglutinating 
preparations  gave almost identical  degrees of hemolysis but  the  third  (HAL- 
43)  had a  considerably greater hemolytic effect. The lysis of IgM-coated cells 
was unaffected. 
TABLE VII 
Effect oj Increase in the Amount of Rheumatoid Factor Preparation upon Complement-Mediated 
Lysis of Erflhrocytes Coated "~th 0.I Optimal A mount of IgG Hemolysin or with 0.01 Optimal 
IgM Hemolysin 
Rheumatoid factor  SCAT* 
Relative rheumatoid/actor concentration 
0  0.25  1.0  4.0 
0.1 IgG hemolysin 
HAL--43  2048  2  62  74  82 
WEG--42  2048  2  12  28  34 
VAN--4I  2048  2  15  27  43 
0.01 IgM hemolysin 
HAL--43  2048  5  1  1  1 
WEG--42  2048  5  1  1  1 
VAN--41  2048  5  1  1  0 
Values refer to the percentage of lysis observed in the presence of 8.5 CHs0 units of com- 
plement. 
* Sheep red  cell agglutination  test  for rheumatoid  factor; reciprocal  of maximum  pos- 
itive dilution. SCAT titer refers to strength of the preparation  at 1.0 concentration. 
Effect of Complement and its Clq Component on the Degree of Hemolysis Observed 
in the Presence of Rheumatoid Factor 
Complement.--The  interaction  between  complement and  the hemolysin and 
RF  components on  the  erythrocyte membrane was studied  over the range  of 
0.1-1.0 unit  IgG antibody sensitization  to further  define  the  complement  re- 
quirements of the system. The results obtained with 0.2 and 1.0 unit of hemoly- 
sin are illustrative of the trend observed (Fig. 4), with enhancement at the lower 
level and inhibition at the higher level of sensitization. 
When complement activity is expressed as a percentage of the maximum ob- 
servable with optimally sensitized cells,  this paradoxical effect of RF  on  com- 
plement consumption is readily seen (Fig. 5). At approximately one-third opti- 
mal IgG hemolysin concentration on the erythrocyte, RF exerted no measurable 
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above that point required a substantially greater amount of IgG hemolysin in 
the presence of RF, while below that point required less IgG hemolysin. 
Effects  of Sequential Addition of Clq and Rheumatoid Factor.--Kinetic experi- 
ments on the inhibition of complement fixation by RF showed that the over-all 
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F~c.  4.  Plot  of the number of CHs0 units of complement required to lyse red cells coated 
with optimal (1.0)  and suboptimal (0.2)  amounts of IgG antibody in the presence of  rheu- 
matoid factor. RF preparations 25  (m) and 43 (•) had sheep cell agglutination titers of 1/512 
and 1/2048 respectively. -  .... without rheumatoid factor;  with rheumatoid factor. 
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RELATIVE  IgG  HEMOLYSIN  CONCENTRATION 
FIG. 5.  Effect of rheumatoid factor preparations upon complement activity achieved with 
varying concentrations of IgG hemolysin. Data plotted from  the type of experiment illus- 
trated in Fig. 4 utilizing three preparations, numbers 25 (SCAT titer 1/512), 41, and 42 (both 
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sigmoid shape of the curve was not grossly altered but that the rate of cell lysis 
was reduced and in the period from 45 to 90 rain there was only a slight increase 
in hemolysis (Fig. 6). The effect of varying the order of addition of Clq and RF 
was studied.  In one case RF was added to the sensitized ceils  10 rain before a 
Clq preparation,  the reaction system being completed after a further  10 rain 
by addition of an Rlq reagent, while  another reaction mixture was set up with 
Clq first,  followed 10 rain later by RF plus the Rlq reagent.  The rate of cell 
lysis obtained with prior addition of Clq was comparable to that seen in the 
absence of RF over the initial  15 rain, but thereafter inhibition became evident. 
0,14 r  _  fl/.......~  RF absent 
/  ~-.s  ~..,,,~.,.o  R  F a f t e  r Clq 
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FIG. 6.  Effect of sequence of addition of Clq and rheumatoid factor on the rate of lysis o 
sensitized cells in the presence of Rlq reagent. Sequence of addition of reagents to sensitized 
cells: •  •;Clq, -10min;Rlq-k RF, 0min.  O----O;RF,--2Omin;Clq,--lOmin; 
Rlq, 0 min. VI----D  ; Clq, -  10 min; Rlq, 0 min. 
In all stages of the reaction the degree of hemolysis was only marginally greater 
than that found when RF had been added first. 
Effect of Red Blood Cell Agglutinalion  on Hemolysis 
During the incubation period in which lysis occurred, macroscopic agglutina- 
tion of red cells  developed in mixtures containing RF, small aggregates some- 
times persisting despite periodic shaking of the mixture during incubation. This 
was not evident at suboptimal levels  of antibody sensitization.  The possibility 
was therefore entertained  that agglutination per se either inhibited the release 
of hemoglobin from cells  or did  not  allow ready access of  complement com- 
ponents to available sites through close packing of the cells. To test this possi- 
bility,  hemolysis was  determined  in  the  presence  of phytohemagglutinin,  an FRANK R.  SCItMID, IVAN M.  ROITT, AND  MARIA ~.  ROCHA  687 
agglutinator that acts directly on the red cell (Table VIII). When degrees of 
macroscopic agglutination were achieved similar to those found in the rheuma- 
toid system, barely detectable interference with lysis occurred. Only when the 
cells agglutinated to form a  single mass was it possible to inhibit lysis to a  sig- 
nificant degree. It should be mentioned that the degree of agglutination which 
occurred in  the RF  system became  evident only after  15-20 rain incubation 
so that adequate time wotfld be available for reacting complement components 
to have access to the cell membrane. Indeed, in the presence of excess comple- 
ment, complete lysis would still be achieved despite the presence of strong ag- 
glutination. 
TABLE VIII 
Effect  of Macroscopic Agglutination  Caused by Phytohemagglutinin  M  (PHA-M)  on the 
Susceptibility  of Optimally  Sensitized  Sheep Erythrocytes to Immune Lysis 
Incubation time  CHs0 units assayed 
of PHA-M  and  Degree of  Class of 
RBC prior to  macroscopic  hemolysin  PHA-M  PHA-M  addition  of  agglutination  complement  absent  present 
(rain) 
10  None  IgM  30.3  28.6 
15  Moderate  IgM  27.8  25.0 
15  "  IgM  35.7  37.5 
15  "  IgG  33.4  30.0 
23  "  IgM  30.3  28.6 
35  "  IgM  30.3  28.6 
90  Solid  IgM  33.3  21.3 
DISCUSSION 
These studies demonstrate that IgM rheumatoid  factor, after its interaction 
with IgG antibody on the erythrocyte  membrane, causes a paradoxical  response 
in  complement fixation--enhancement at lower concentrations of  IgG  and 
inhibition at higher concentrations. The  reaction in  either direction is  ac- 
centuated by increased concentrations of RF. 
In assessing the influence  of RF on this system, it is important to distinguish 
between the effect caused by nonspecific complement-consuming reactions in 
the fluid  phase in contrast to the specific  binding of complement  to antibody on 
the cell surface. A competing  fluid phase reaction must be considered  since RF 
was first eluted from  an immunoabsorbant of human gamma globulin and then 
bound to rabbit IgG hemolysin  on the erythrocyte.  That portion of the RF with 
affinity  for human but less affinity  for rabbit IgG (14) might therefore  be avail- 
able to bind to the aggregated  IgG conceivably  present in the system. Any fluid 
phase reaction, however,  was controlled  in the design of the present study by 
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hemolysin to which it does not. RF caused no significant changes in complement 
fixation  by cells  coated  with  either  optimal  or  suboptimal  amounts  of IgM 
hemolysin whereas striking changes were noted with IgG-coated cells. As noted 
below, earlier studies investigating the interaction of RF and complement did 
not  always exclude  this fluid-phase  effect with  their  eug]obulin  preparations. 
Furthermore, when red cells coated with IgG hemolysin and RF were washed to 
remove unbound reactants,  they still behaved in the same fashion as cells not 
washed  to  which  complement  was  added.  Finally,  when  RF  inhibited  the 
hemolysis of cells coated with optimal amounts of IgG, complement was spared 
and could be recovered completely in the fluid phase. 
That IgM rheumatoid factor, rather than some other constituent in rheuma- 
toid serum, was the effective agent on the cell membrane was evident from both 
the  activity of purified RF  and  the loss  of activity after absorption with  in- 
soluble gamma globulin. In addition,  there was a good correlation between the 
agglutinating  titer of purified RF and the degree  to which  it influenced  com- 
plement fixation. 
It is  highly  unlikely  in  the  face  of  this  evidence  that  other  substances  in 
human serum could have been active in conjunction  with  or in place of RF. 
Significant  amounts  of  natural  or  heterophile  antibody  against  sheep  cells 
found in almost all human sera were removed by prior absorption procedures, 
and  trace  amounts,  if any,  that  might have been left behind  would  lyse the 
control unsensitized erythrocytes. Subthreshold amounts of these antibodies in 
conjunction with IgG hemolysin might have the potential of binding comple- 
ment but no fixation could be detected by even more rigorous absorption pro- 
cedures carried out on a single RF preparation. Although rheumatoid sera con- 
tain  immunoconglutinin  (15)  and  this  might  have  contaminated  the  RF 
preparations, it seems unlikely that the effects observed on the IgG hemolysin 
system could  be attributed  to  this  protein  since  comparable changes  should 
have been observed with IgM-coated erythrocytes. Heimer et al., using erythro- 
cytes  sensitized  with  whole  rabbit-hemolytic serum,  attributed  inhibition  of 
complement fixation to a macromolecule other than rheumatoid factor (3). Its 
nature  was not  estabilshed  but  it lacked  the  ability  to  agglutinate  globulin- 
coated  particles  and  resided  in  a  slightly  different region  of  the  peak eluted 
from DEAE-cellulose  by 0.3  M salt solutions  than  did  RF.  However,  in  the 
present report,  the active material isolated from serum fulfilled the generally 
accepted criteria for RF (16). 
The inhibitory effect of RF is presumably linked  to its ability to sterically 
inhibit the reactions of bound Clq or more probably to its competitive displace- 
ment of Clq from the IgG heavy chain. The loose binding of Clq to antibody, 
recognized for intact C1  complex by other workers (17),  was demonstrated in 
our kinetic experiments. Clq was added to cells sensitized with high concentra- 
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by the introduction of the remaining complement components. The initial rate 
of lysis approximated that seen in the absence of RF,  but after a  period of 
approximately 15 rain inhibition became apparent and the speed of the reaction 
fell to that obtained in the system in which RF had been added before Clq. 
This changeover in reaction rate would support the view that RF displaced 
Clq from its binding to IgG. 
Earlier reports emphasized an inhibitory effect of RF on the ability of com- 
plement to fix to IgG coated onto particulate carriers. These included studies 
on the binding of complement by IgG on sheep red cells (3), latex particles (18, 
19), and mitochondrial subfractions (20)  where the concentration of  the im- 
munoglobulin coat was not a  limiting factor. The inhibition observed in the 
present work using sheep cells coated optimally with IgG is fully consistent with 
these findings. The paradoxical enhancing effect of RF seen with suboptimal 
IgG hemolysin coats can probably be accounted for in terms of direct fixation 
of complement by the RF itself, as has been independently demonstrated by 
others (6, 8). At low concentrations, the IgG antibody fixes complement poorly 
but is  still capable of binding RF,  as evidenced by  agglutination reactions? 
The fixation of complement by this bound RF, although of a relatively weak 
order, is greater than that obtained with the IgG antibody alone. On the other 
hand,  the red  cells  coated with optimal  amounts of IgG hemolysin fix con- 
siderably more  complement and  this  is  reduced by  addition of  RF;  on  the 
simplest view RF blocks the complement-binding activity of IgG and substi- 
tutes its  own relatively weak reactivity. Parallel  studies using IgG reactant 
pretreated with 2-mercaptoethanol  accord with this interpretation.  ~ In other 
words,  the  RF  interaction with  IgG generates  only a  limited ability to  fix 
complement; when contrasted to the fixation at suboptimal concentrations of 
IgG alone, the net result appears  as enhancement but when contrasted with 
that at an optimal coat of IgG, the net result is inhibition (Figs. 5 and 7). 
Since RF influences complement action in vitro, the possible involvement of 
this effect in biologic  systems is  of interest.  Evidence has  accumulated that 
complement fixation occurs within the synovial fluids  of patients with  sero- 
positive rheumatoid arthritis  (21, 22).  Soluble IgG complexes of such fluids, 
possibly containing anti-globulins of IgG class, fix complement in vitro and are 
associated with low levels in vivo (23).  The number of  cellular inclusions in 
polymorphonuclear phagocytes of joint fluids from seropositive patients  are 
related to high titers of IgM-RF and to lowered joint fluid complement levels 
(24). If purified IgM-RF is added to synovial fluids of patients with seronegative 
rheumatoid disease,  cellular  inclusions form within polymorphonuclear cells 
(25), perhaps in the same manner in which IgM-RF increases the phagocytosis 
of aggregated IgG in vitro (26).  Less is known of the effects of RF in tissues 
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outside  the  joint  but  several  clinical  situations  suggest  a  possible role  (27). 
Recently, in the experimental model of nephrotoxic nephritis, RF appeared to 
enhance the degree of renal inflammation  (28).  Thus,  the likelihood must be 
entertained  that  RF  is  an  active agent in  the pathogenesis  of tissue inflam- 
mation. 
Whether  the  contrary  circumstance  of  inhibition  of  complement  fixation 
occurs in vivo remains to be explored. In a tissue culture system complement- 
dependent cytolysis of human thyroid cells was shown to be partially inhibited 
FIG.  7.  Diagrammatic representation to illustrate a  possible mechanism of action of RF 
for relative enhancement of complement fixation at suboptimal levels of IgG sensitization of 
the erythrocyte membrane and inhibition at optimal levels. 
by IgM-RF (4). Gough and Davis have suggested that IgM-RF might trap im- 
mune complexes in joint fluids,  thereby excluding them from the vascular com- 
partment  and  protecting other organs  of the body, for example,  the kidney, 
from the damaging effects of circulating soluble complexes (29). 
It may be that in vivo as well as in vitro RF plays a dual role. Where local 
circumstances favor its ability to enhance complement fixation, perhaps in the 
joint or when bound to membranes coated with suboptimal  amounts of anti- 
body, it potentiates the inflammatory response. On other cell membranes sensi- 
tized by larger amounts of IgG antibody to which RF binds, it is possible that a FRANK R.  SCHMID, IVAN M.  ROITT, AND MARIA J.  ROCHA  691 
less  effective site for complement fixation is offered,  thereby blunting  the in- 
tensity of the inflammatory response. 
SUMMARY 
Complement-mediated lysis of sheep erythrocytes coated with optimal con- 
centrations of rabbit IgG hemolysin was inhibited by euglobulin fractions from 
the sera of patients with seropositive rheumatoid arthritis.  That this was due 
to direct interaction with the IgG coat on the red cell rather than a nonspecific 
reaction with complement in the fluid phase was confirmed by controls using 
cells  coated with  IgM hemolysin.  The  inhibitory  activity  was  recovered  in 
purified IgM rheumatoid factor preparations  and could be absorbed out with 
insoluble  aggregated human IgG. The inhibitory potency'of the  rheumatoid 
factors correlated well with their sheep cell agglutination titers. Inhibition was 
not the result of physical aggregation of the erythrocytes by rheumatoid factor. 
Kinetic studies were consistent with the view that rheumatoid factor displaces 
Clq from its binding to IgG. Paradoxically, at suboptimal sensitizing concen- 
trations of IgG hemolysin, rheumatoid factor enhances the fixation of comple- 
ment. These results can be interpreted on the basis of the blockage of comple- 
ment fixation by IgG and its replacement by a relatively weak direct fixation 
by the IgM rheumatoid factor. Thus, the interaction of RF with IgG generates 
only a limited ability to fix complement which, when contrasted with the fixa- 
tion  at  suboptimal  concentrations  of  IgG  hemolysin  alone,  appears  as  net 
enhancement; when this is contrasted with fixation occurring with optimal con- 
centrations of IgG, it appears as net inhibition. 
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